Cargando…

The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems

The availability of effective, accessible, safe and high-quality anticancer drugs for the medical treatment of cancer is fundamental in ensuring optimal healthcare in the public health system in Peru. The main objective is to assess the current situation regarding anticancer drugs (termed ‘high-cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Valencia-Mesías, Guillermo, Rioja-Viera, Patricia, Morante-Cruz, Zaida, Toledo-Morote, Yura, Neciosup-Delgado, Silvia, Gómez-Moreno, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183645/
https://www.ncbi.nlm.nih.gov/pubmed/34158828
http://dx.doi.org/10.3332/ecancer.2021.1224
_version_ 1783704412772892672
author Valencia-Mesías, Guillermo
Rioja-Viera, Patricia
Morante-Cruz, Zaida
Toledo-Morote, Yura
Neciosup-Delgado, Silvia
Gómez-Moreno, Henry
author_facet Valencia-Mesías, Guillermo
Rioja-Viera, Patricia
Morante-Cruz, Zaida
Toledo-Morote, Yura
Neciosup-Delgado, Silvia
Gómez-Moreno, Henry
author_sort Valencia-Mesías, Guillermo
collection PubMed
description The availability of effective, accessible, safe and high-quality anticancer drugs for the medical treatment of cancer is fundamental in ensuring optimal healthcare in the public health system in Peru. The main objective is to assess the current situation regarding anticancer drugs (termed ‘high-cost’) for breast cancer, as well as an analysis of the possible factors which negatively impact access to the Peruvian public health systems.There are similarities in the availability of anticancer drugs, since most treatments are covered by the Peruvian Ministry of Health. EsSalud offers an extra monoclonal antibody (pertuzumab) in the metastatic treatment stage. Meanwhile, the National Institute of Neoplastic Diseases (INEN), mainly for metastatic disease, has relied on more tested treatments over the last year. An agreement has been reached with the armed forces, which will enable patients to receive oncology care at the INEN and, thereby, benefit from the use of high-cost drugs.
format Online
Article
Text
id pubmed-8183645
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-81836452021-06-21 The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems Valencia-Mesías, Guillermo Rioja-Viera, Patricia Morante-Cruz, Zaida Toledo-Morote, Yura Neciosup-Delgado, Silvia Gómez-Moreno, Henry Ecancermedicalscience Short Communication The availability of effective, accessible, safe and high-quality anticancer drugs for the medical treatment of cancer is fundamental in ensuring optimal healthcare in the public health system in Peru. The main objective is to assess the current situation regarding anticancer drugs (termed ‘high-cost’) for breast cancer, as well as an analysis of the possible factors which negatively impact access to the Peruvian public health systems.There are similarities in the availability of anticancer drugs, since most treatments are covered by the Peruvian Ministry of Health. EsSalud offers an extra monoclonal antibody (pertuzumab) in the metastatic treatment stage. Meanwhile, the National Institute of Neoplastic Diseases (INEN), mainly for metastatic disease, has relied on more tested treatments over the last year. An agreement has been reached with the armed forces, which will enable patients to receive oncology care at the INEN and, thereby, benefit from the use of high-cost drugs. Cancer Intelligence 2021-04-27 /pmc/articles/PMC8183645/ /pubmed/34158828 http://dx.doi.org/10.3332/ecancer.2021.1224 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Valencia-Mesías, Guillermo
Rioja-Viera, Patricia
Morante-Cruz, Zaida
Toledo-Morote, Yura
Neciosup-Delgado, Silvia
Gómez-Moreno, Henry
The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
title The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
title_full The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
title_fullStr The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
title_full_unstemmed The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
title_short The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
title_sort current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the peruvian public health systems
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183645/
https://www.ncbi.nlm.nih.gov/pubmed/34158828
http://dx.doi.org/10.3332/ecancer.2021.1224
work_keys_str_mv AT valenciamesiasguillermo thecurrentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT riojavierapatricia thecurrentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT morantecruzzaida thecurrentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT toledomoroteyura thecurrentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT neciosupdelgadosilvia thecurrentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT gomezmorenohenry thecurrentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT valenciamesiasguillermo currentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT riojavierapatricia currentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT morantecruzzaida currentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT toledomoroteyura currentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT neciosupdelgadosilvia currentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems
AT gomezmorenohenry currentsituationregardingtheavailabilityandaccessibilityofanticancerdrugsforbreastcancerintheperuvianpublichealthsystems